CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
CorEvitas
Study ID
NCT06238765
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
12 Years - 15 Years
Healthy Volunteers
Accepted

Study Details

Prospective observational registry for an adolescent cohort with AD under the care of a dermatology provider. Approximately 1500 subjects and 75 clinical sites in North America and select European countries will be recruited to participate with no defined upper limit for either target.

Key Dates

Start date
Dec 2, 2023
Status verified
Jan 2026
Primary completion
Dec 31, 2099
Completion
Dec 31, 2099

Study Design

Enrollment
1,500 participants (estimated)

Primary Outcome Measure

AD epidemiology, presentation, natural history, management, and outcomes [ Time Frame: Through Study completion until the subject is 18 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
CorEvitas, LLCWalthamMassachusetts02451
Cathy Cheney
[email protected]
508-555-1212

Find similar trials in Waltham, MA

By condition
Atopic dermatitis / eczema
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
CorEvitas, LLC· Waltham, MA

Related Studies